Related Experiment Videos
Intrathoracic granular cell myoblastoma.
J M Robinson1, R Knoll, D A Henry
1Department of Radiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
Southern Medical Journal
|November 1, 1988
Summary
Intrathoracic granular cell myoblastoma (GCM) is a benign Schwann cell tumor typically found in the airways or mediastinum. Surgical or endoscopic resection is the preferred treatment, offering a good prognosis with complete tumor removal.
Area of Science:
- Thoracic oncology
- Neoplastic pathology
- Surgical pathology
Background:
- Intrathoracic granular cell myoblastoma (GCM) is a rare, typically benign neoplasm originating from Schwann cells.
- It most commonly affects the large airways (tracheobronchial) or mediastinum.
- The tumor predominantly occurs in Black individuals in their fourth decade, with no significant sex predilection.
Observation:
- Tracheobronchial GCM often presents with cough and chest pain, potentially showing consolidation or atelectasis on chest X-rays.
- Extraesophageal mediastinal GCM is often asymptomatic and presents as a posterior mediastinal mass.
- Computerized tomography (CT) aids in assessing lesion extent and relationship to adjacent structures.
Findings:
- Diagnosis of tracheobronchial GCM is typically achieved through bronchoscopy and biopsy.
- Surgical or endoscopic resection is generally considered the treatment of choice, though management remains debated.
- Complete tumor removal is crucial for a favorable prognosis.
Implications:
- Early diagnosis and complete resection are key for managing intrathoracic granular cell myoblastoma.
- Understanding the varied presentations of GCM is important for differential diagnosis of thoracic masses.
- Further research may clarify optimal treatment strategies for this rare tumor.